Atea Pharmaceuticals (AVIR) FCF Margin (2021)
Atea Pharmaceuticals (AVIR) has 1 years of FCF Margin data on record, last reported at 39.25% in Q4 2021.
- For Q4 2021, FCF Margin changed N/A year-over-year to 39.25%; the TTM value through Sep 2022 reached 92.0%, down 28481.0%, while the annual FY2021 figure was 24.76%, 63486.0% down from the prior year.
- FCF Margin reached 39.25% in Q4 2021 per AVIR's latest filing, down from 68.89% in the prior quarter.
- Across five years, FCF Margin topped out at 68.89% in Q3 2021 and bottomed at 39.25% in Q4 2021.